- December 22, 2021
- MediBang
Ecstasy Elf Shotenken -Naruru's Sexy Adventure-
Platforms
Buy Now
About Ecstasy Elf Shotenken -Naruru's Sexy Adventure-
Ecstasy Elf Shotenken -Naruru's Sexy Adventure- is a single player role playing game with fantasy, anime and erotic themes. It was developed by MediBang and was released on December 22, 2021. It received neutral reviews from players.
OverviewExplore the city with Naruru, the Kung-Fu master.The main story will move forward whether you win or lose the Colosseum battles.See what happens when you lose, check out the various shops around town, and talk to the townspeople.StoryNaruru, abandoned as a child, was raised by a Shotenken master.One day, she enters a fighting tournament at Ramsden to find her master who went missing.But as…
Games Like Ecstasy Elf Shotenken -Naruru's Sexy Adventure-
Looking for games like Ecstasy Elf Shotenken -Naruru's Sexy Adventure-? Here are top role playing recommendations with a fantasy, anime and erotic focus, selected from player-similarity data — start with Robot girl's dream -RobotBattleChampionship-, Shantae and the Pirate's Curse or StellaGale: The Trials of Faith.
Buy Ecstasy Elf Shotenken -Naruru's Sexy Adventure-
Frequently Asked Questions
Ecstasy Elf Shotenken -Naruru's Sexy Adventure- is a role playing game with fantasy, anime and erotic themes. Common tags for Ecstasy Elf Shotenken -Naruru's Sexy Adventure- include indie, 2d, difficult, dungeon crawler and elf.
Ecstasy Elf Shotenken -Naruru's Sexy Adventure- is available on Windows.
Ecstasy Elf Shotenken -Naruru's Sexy Adventure- was released on December 22, 2021.
Ecstasy Elf Shotenken -Naruru's Sexy Adventure- was developed by MediBang.
Ecstasy Elf Shotenken -Naruru's Sexy Adventure- has received neutral reviews from players.
Ecstasy Elf Shotenken -Naruru's Sexy Adventure- is a single player game.
Similar games include Robot girl's dream -RobotBattleChampionship-, Shantae and the Pirate's Curse, StellaGale: The Trials of Faith, Midnight's Blessing, Touhou Genso Wanderer Reloaded and others.